NCT00605852View on ClinicalTrials.gov

Investigation Of a New Oral Anti-Histamine in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

October 29, 2007

Primary Completion Date

May 3, 2008

Study Completion Date

May 3, 2008

Conditions

Rhinitis, Allergic, Seasonal

Interventions

DRUG

GSK835726

GSK835726 will be available in single dose and repeat dose formulations.

DRUG

Placebo

Placebo will be given to subjects.

Trial Locations (1)

NW10 7EW

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY